Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up-Reference-Cited by-同舟云学术

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Published:2018-10 Issue: Volume:29 Page:iv238-iv255
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Vogel A.,Cervantes A.,Chau I.,Daniele B.,Llovet J.M.,Meyer T.,Nault J -C,Neumann U.,Ricke J.,Sangro B.,Schirmacher P.,Verslype C.,Zech C.J.,Arnold D.,Martinelli E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/Supplement_4/iv238/27695956/mdy308.pdf

Reference139 articles.

1. Future of hepatocellular carcinoma incidence in the United States forecast through 2030;Petrick;J Clin Oncol,2016

2. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012;White;Gastroenterology,2017

3. Globoscan. http://globocan.iarc.fr/old/FactSheets/cancers/liver-new.asp

4. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

5. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group;Chang;N Engl J Med,1997

Cited by 755 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limited utility of routine bone scintigraphy in the staging of patients with hepatocellular carcinoma: A cross-sectional study;Annals of Hepatology;2024-11

2. Dual-reporter fluorescent probe for precise identification of liver cancer by sequentially responding to carboxylesterase and polarity;Talanta;2024-10

3. [⁶⁸Ga]Ga-RAYZ-8009: A Glypican-3–Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging—A First-in-Human Case Series;Journal of Nuclear Medicine;2024-09-12

4. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma;Molecular Cancer;2024-09-06

5. Sorafenib-mediated cleavage of p62 initiates cellular senescence as a mechanism to evade its anti-hepatocellular carcinoma efficacy;Oncogene;2024-09-04